Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 343421 - 343440 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L04AC07) tocilizumab | Tyenne 20 mg/ml | 1 x 4 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab | RoActemra 20 mg/ml | 4 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab | RoActemra 20 mg/ml | 4 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab | RoActemra 20 mg/ml | 4 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC12) brodalumab | Kyntheum 210 mg | 2 x 1.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 210 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | LEOPHARMAA/S(Danmark) |
| Norway | (L04AC13) ixecizumab | Taltz 80 mg | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 80 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | EliLillyandCompany(Ireland)Limited |
| Norway | (L04AC14) sarilumab | Kevzara 150 mg | 2 x 1.14 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiWinthropIndustrie |
| Norway | (L04AC14) sarilumab | Kevzara 200 mg | 2 x 1.14 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 200 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiWinthropIndustrie |
| Norway | (L04AC16) guselkumab | Tremfya 100 mg | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 100 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | Janssen-CilagInternationalN.V. |
| Norway | (L04AC16) guselkumab | Tremfya 100 mg | 1 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 100 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | Janssen-CilagInternationalN.V. |
| Norway | (L04AC18) risankizumab | Skyrizi 360 mg | 360 mg, Sylinderampulle, Injeksjonsvæske, oppløsning i sylinderampulle, 360 mg , Sylinderampulle | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic | AbbVieDeutschlandGmbH&Co |
| Norway | (L04AC18) risankizumab | Skyrizi 150 mg | 150 mg, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic | AbbVieDeutschlandGmbH&Co |
| Norway | (L04AC18) risankizumab | Skyrizi 75 mg | 2 x 0.83 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 75 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic | AbbVieDeutschlandGmbH&Co |
| Norway | (L04AC18) risankizumab | Skyrizi 600 mg | 600 mg, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic | AbbVieDeutschlandGmbH&Co |
| Norway | (L04AC19) satralizumab | Enspryng 120 mg | 1 x 120 mg, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 120 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | RocheRegistrationGmbH |
| Norway | (L04AC21) bimekizumab | Bimzelx 160 mg | 2 x 160 mg, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 160 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | UCBPharmaS.A.(2) |
| Norway | (L04AC21) bimekizumab | Bimzelx 160 mg | 2 x 160 mg, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 160 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | UCBPharmaS.A.(2) |
| Norway | (L04AC22) spesolimab | Spevigo 450 mg | 2 x 7.5 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 450 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimInternationalGmbH |
Pages
